Trials / Completed
CompletedNCT07506252
Influence of Hydration Status on the Yield of Injectable Platelet-Rich Fibrin
Influence of the Drinking Amount on the Autologous Blood in the Centrifuge Contained Fibrin Matrix - Platelet-rich Fibrin A Randomized Controlled Pilot Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 26 (actual)
- Sponsor
- Medical University of Graz · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Due to the current lack of evidence regarding the influence of fluid intake on the amount of leukocyte- and platelet-rich fibrin fraction present in blood samples, this study aims to investigate the positive influence of this factor on the body's own matrix. Platelet-rich fibrin, a fibrin-rich autologous matrix obtained from autologous blood via centrifugation, contains not only fibrin but also important growth factors and a large number of white blood cells, all of which make a significant contribution to tissue regeneration. The obtained fibrin matrix can be used as a membrane, as a clot (A-PRF), or as a liquid (i-PRF) to positively influence the healing process. The novelty of this work lies in shifting the focus from purely technical centrifugation parameters to a patient-centered, easily modifiable biological variable. Hydration status represents a low-cost, non-invasive, and immediately applicable strategy to optimize autologous blood concentrates. These findings are directly relevant to clinicians seeking to enhance the predictability and efficiency of PRF-based regenerative procedures in implant dentistry.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Hydration following a drinking protocol | Participants followed a drinking protocol the day before the measurement to reach euhydration |
Timeline
- Start date
- 2022-12-12
- Primary completion
- 2023-05-19
- Completion
- 2023-05-19
- First posted
- 2026-04-01
- Last updated
- 2026-04-01
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT07506252. Inclusion in this directory is not an endorsement.